Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2016, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2016-06-29
DOI
10.1155/2016/5706814
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of RetroNectin-Activated Cytokine-Induced Killer Cell Therapy in Metastatic Brain Tumor Patients
- (2015) Wei Li et al. Oncology Research and Treatment
- Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas
- (2013) D. Sangiolo et al. CANCER RESEARCH
- Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features
- (2013) L. Gammaitoni et al. CLINICAL CANCER RESEARCH
- Effectivity of Long Antigen Exposition Dendritic Cell Therapy (LANEXDC®) in the Palliative Treatment of Pancreatic Cancer
- (2013) F. Gansauge et al. CURRENT MEDICINAL CHEMISTRY
- Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma
- (2013) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytokine-induced killer cells promote antitumor immunity
- (2013) Jingting Jiang et al. Journal of Translational Medicine
- Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma
- (2012) Clara E. Jäkel et al. Clinical & Developmental Immunology
- Randomized Study of Autologous Cytokine-Induced Killer Cell Immunotherapy in Metastatic Renal Carcinoma
- (2012) L. Liu et al. CLINICAL CANCER RESEARCH
- Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors
- (2012) Giulia Mesiano et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Synergistic Effect of CH-296 and Interferon Gamma on Cytokine-Induced Killer Cells Expansion for Patients with Advanced-Stage Malignant Solid Tumors
- (2011) Jinpu Yu et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation
- (2010) Haiqing Ma et al. CANCER BIOLOGY & THERAPY
- Retronectin enhances lentivirus-mediated gene delivery into hematopoietic progenitor cells
- (2009) Hyun-Joo Lee et al. BIOLOGICALS
- Circulating Mesothelin Protein and Cellular Antimesothelin Immunity in Patients with Pancreatic Cancer
- (2009) F. Mc. Johnston et al. CLINICAL CANCER RESEARCH
- Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial
- (2009) Paola Olioso et al. HEMATOLOGICAL ONCOLOGY
- In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity
- (2008) R. Nishimura et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started